Major salivary gland involvement in graft-versus-host disease: Considerations related to pathogenesis, the role of cytokines and therapy

Cytokines, Cellular and Molecular Therapy

Volumn 5, Issue 4, 1999, Pages 227-232

  Nagler, Rafael M ^a,c   Nagler, Arnon ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c NONE   (Israel)

Author keywords

Cytokines; Graft versus host disease; Pilocarpine hydrochloride; Salivary glands; Xerostomia

Indexed keywords

CYTOKINE; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; GRAFT VERSUS HOST REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVARY GLAND; STEM CELL TRANSPLANTATION;

ANIMALS; CYTOKINES; GRAFT VS HOST DISEASE; HUMANS; SALIVA; SALIVARY GLANDS;

EID: 0033506336     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Rosales F, Peylan-Ramu N, Cividalli G et al, The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases. Bone Marrow Transplant (1999) 23: 861-5.
2. Hill GR, Cooke KR, Brinson YS et al, Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation (1999) 67: 1478-80.
3. Baurmann H, Nagel S, Binder T et al, Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood (1998) 92: 3582-90.
4. Izutsu KT, Sullivan KM, Schubert MM et al, Disordered salivary immunoglobulin secretion and sodium transport in human graft-versus-host disease. Transplantation (1983) 35: 441-6.
5. Chaushu S, Chaushu G, Garfunkle AA et al, Immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor-derived salivary IgA following major transplantation of T cell-depleted bone marrow. Bone Marrow Transplant (1994) 14: 925-8.
6. Chaushu S, Chaushu G, Garfunkle AA et al, Salivary immunoglobulins in recipients of bone marrow grafts. I. A longitudinal follow-up. Bone Marrow Transplant (1994) 14: 871-6.
7. Mandel ID, The role of saliva in maintaining oral homeostasis. J Am Dent Assoc (1989) 119: 298-304.
8. Fox PC, Van Der Van P, Sonies BC et al, Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc (1985) 110: 519-25.
9. Hirozane A, Fujikura Y, Sawada T et al, Analysis of major histo-compatibility complex [mhc] class I antigen rat saligland. Arch Oral Biol (1992) 37: 147-51.
10. Saitoh T, Fujiwara M, Asakura H, Ductal lesions of exocrine glands and insulitis induced by 13t4+ T cells following graft-versus-host reaction due to major histocompatibility complex class II disparity. Clin Immunol Immunopathol (1990) 57: 339-50.
11. Nagler RM, Laufer D, Nagler A, Parotid gland dysfunction in a murine model of acute graft versus host disease. Head & Neck (1998) 20: 58-62.
12. Nagler RM, Laufer D, Nagler A, Parotoid gland dysfunction in an animal model of chronic graft versus host disease. Arch Otolaryngol Head Neck Surg (1996) 122: 1057-60.
13. Driezen S, Mccredie KB, Dicke KA et al, Oral complications of bone marrow transplantation. Postgrad Med J (1979) 66: 187-96.
14. Sale GE, Shulman HM, Schubert MM et al, Oral and ophthalmic pathology of graft-versus-host disease in man: predictive value of lip biopsy. Hum Pathol (1981) 12: 1022-30.
15. Lindahl G, Lonnquist B, Hedfors E, Lymphocytic infiltration and HLA-DR expression of salivary glands in bone marrow transplant recipients: a prospective study. Clin Exp Immunol (1988) 72: 267-73.
16. Nagler A, Barak V, Slavin S, The role of cytokines in graft versus host reactions and rejection following allogeneic bone marrow. In: Human Cytokines: Their Role in Disease and Therapy (ed RK Puri, BB Aggarwal) 153-61. Blackwell Publications, Oxford, 1995.
17. Nagler RM, Marmary Y, Krausz Y et al, Salivary gland dysfunction in human acute and chronic graft versus host disease (GVHD). Bone Marrow Transplant (1996) 17: 219-24 .
18. Nagler RM, Sherman Y, Nagler A, Histopathologic study of the human sub-mandibular gland in graft versus host disease. J Clin Pathol (1999) 52: 395-7.
19. Nagler RM, Nagler A, Sialometrical and sialochemical analysis of pilocarpine hydrochloride administration in chronic graft vs host disease patients. International Association of Dental Research - Israeli division meeting. Jerusalem, Israel. 1999.
20. Hiroki A, Nakamura S, Shinohara M, Oka M, Significance of oral examination in chronic graft-versus-host disease. J Oral Pathol Med (1994) 23: 209-15.
21. Yamauchi K, Noguchi K, Suzuki Y, Nagao T, Gallium-67 uptake in the salivary glands in chronic graft-versus-host disease after bone marrow transplantation. Clin Nucl Med (1989) 14: 330-2.
22. Izutsu KT, Schubert MM, Trulove EL et al, The predictive value of elevated labial saliva sodium concentration: its relation to labial gland pathology in bone marrow transplant recipients. Hum Pathol (1983) 14: 29-35.
23. Nagler A, Nagler RM, Ackerstein A et al, Major salivary gland dysfunction in patients with hematological malignancies receiving interleukin-2 based immunotherapy post autologous blood stem cell transplantation. Bone Marrow Transplant (1997) 20: 575-80.
24. Neudorf S, Filipovich A, Ramsay N, Kersey J, Prevention and treatment of acute graft-versus-host disease. Semin Hematol (1984) 21: 91-100.
25. Nagler RM, Nagler A, Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease patients: a sialometrical study. Bone Marrow Transplant (1999) 23: 1007-11.
26. Singhal S, Mehta J, Rattenbury H et al, Oral pilocarpine hydrochloride for the treatment of refractory xerostomia associated with chronic graft-versus-host disease. Blood (1995) 85: 1147-8.
27. Singhal S, Powles R, Treleaven J et al, Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone marrow transplantation for hematologic malignancies. Leuk Lymphoma (1997) 24: 539-43.
28. Marmary Y, Shiloni E, Katz Y, Oral changes in interleukin-2 treated patients: a preliminary report. J Oral Pathol Med (1992) 21: 230-1.
29. Marmary Y, Okon E, Katz J, Shiloni E, Effect of interleukin-2 on salivary gland morphology and function in mice. Lymphokine Cytokine Res (1994) 13: 197-201.
30. Katz Y, Weiss H, Goldman B et al, Cytokines and growth factors modulate cell growth and insulin-like growth factor binding protein secretion by the human salivary cell line (HSG). J Cell Physiol (1995) 165: 223-7.
31. Katz J, Nagler RM, Barak S et al, Cytokines modulate interleukin-6 production by human salivary gland cell line. Cell Immunol (1994) 159: 211-9.
32. Nagler RM, Katz J, Laufer D, Nagler A, Irradiation induced injury to the HSG cell line: in vitro model for reproductive cell death in major salivary glands. Cancer Res Ther Control (1995) 4: 173-81.
33. Nagler RM, Effects of radiotherapy and chemotherapeutic cytokines on a human salivary cell line. Anticancer Res (1998) 18: 309-14.
34. Ramsay AJ, Husband AJ, Ramshaw IA et al, The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science (1984) 264: 561-3.
35. Sun D, Emmert-Buck MR, Fox PC, Deferential cytokine mRNA expression in human labial minor salivary glands in primary Sjögren's sydrome. Autoimmunity (1998) 28: 125-37.
36. Yanagi K, Ishimaru N, Haneji N et al, Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome. Euro J Immunol 28: 3336-45.
37. Nagler RM, Effects of radiotherapy and chemotherapeutic cytokines on a human salivary cell line. Anticancer Res (1998) 18: 309-14.
38. Robinson CP, Cornelius J, Bounous DE et al, Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of the autoimmune NOD mice. Autoimmunity (1998) 27: 29-44.
39. Hamano H, Haneji N, Yanagi K et al, Expression of HLA-DR and cytokine genes on interferon-gamma-stimulated human salivary gland cell line. Pathobiology (1996) 64: 255-61.
40. 2+ stores in a human salivary gland cell line. Am J Physiol (1996) 270: 514-21.
41. Hayashi Y, Naheji N, Hamano H et al, Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome. Cell Immunol (1996) 171: 217-25.
42. Ohyama Y, Nakamura S, Matsuzaki G et al, Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (1996) 39: 1376-84.
43. Wu AJ, Chen ZJ, Tsokos M et al, Interferon-gamma induced cell death in a cultured human salivary gland cell line. J Cell Physiol (1996) 167: 297-304.
44. Nagler RM, Kitorsky N, Chevion M, Antioxidant activity of rat parotid saliva. Arch Otolaryngol Head Neck Surg (1997) 123: 989-93.
45. Nagler RM, Baum BJ, Fox PC, Acute effects of x-irradiation on the function of rat salivary glands. Radiat Res (1993) 136: 42-7.
46. Nagler RM, Baum BJ, Fox PC, Effects of x-irradiation on the function of rat salivary glands at 3 and 40 days. Radiat Res (1993) 136: 392-6.
47. Nagler RM, Marmary Y, Fox PC et al, Irradiation induced damage to the salivary glands: the role of redox-active iron and copper. Radiat Res (1997) 147: 468-75.
48. Nagler RM, Nagler A, Laufer D, Sialochemical profile of x-irradiated major salivary glands in the rat. Int J Radiat Biol (1997) 71: 444-8.
49. Nagler RM, Baum BJ, Miller G, Fox PC, Long-term salivary effects of single-dose head and neck irradiation in the rat. Arch Oral Biol (1998) 43: 297-303.